E-Pharma Trento is a leading Contract Development and Manufacturing Organization (CDMO) specializing in solid oral delivery forms for pharmaceuticals and food supplements. With a focus on effervescent, orally disintegrating, soluble, and sublingual products, the company offers a range of services to B2B Pharma Companies, including contract development, contract manufacturing, and out-licensing + supply worldwide under the partners' brand.
Founded in 1993 and headquartered in Italy, E-Pharma Trento operates a state-of-the-art plant in Trento, North Italy, which is authorized to produce pharmaceuticals, including investigational medicinal products, and food supplements. The company holds GMP authorization from AIFA and Russian Health Authorities, and it is registered to produce food supplements by FDA, TGA, and Emirates.
One of the company's strengths lies in its independent research, development, and registration of new pharmaceutical products, leveraging patented technology platforms to offer innovative full-service solutions to its partners. E-Pharma Trento is dedicated to bringing top-quality innovative products to its partners, aiming to enhance their product portfolio with its solid oral delivery forms.
With its slogan, "YOUR PARTNER FOR YOUR NEXT PRODUCT," E-Pharma Trento positions itself as a reference company for solid oral delivery forms, emphasizing its commitment to offering cutting-edge solutions to enhance its partners' offerings in the healthcare, manufacturing, and pharmaceutical industries.
There is no investment information
No recent news or press coverage available for E-Pharma Trento.